Avijarni tuberkulin PPD Croacia - croata - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

avijarni tuberkulin ppd

genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - pročišćeni proteinski derivat (tuberkulin) bakterije mycobacterium avium, soj d 4 er - otopina za injekciju - kokoši, goveda, svinja

Bovini tuberkulin PPD Croacia - croata - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

bovini tuberkulin ppd

genera d.d., svetonedeljska cesta 2, kalinovica, 10436 rakov potok, hrvatska - pročišćeni proteinski detivat (tuberkulin) bakterije mycobacterium bovis, soj an 5 - otopina za injekciju - goveda, svinja

AMINOPLASMAL  B.Braun 10 % E 5 g/1000 mL+ 8.9 g/1000 mL+ 6.85 g/1000 mL+ 4.4 g/1000 mL+ 4.7 g/1000 mL+ 4.2 g/1000 mL+ 1.6 g/1000 Bosnia y Herzegovina - croata - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

aminoplasmal b.braun 10 % e 5 g/1000 ml+ 8.9 g/1000 ml+ 6.85 g/1000 ml+ 4.4 g/1000 ml+ 4.7 g/1000 ml+ 4.2 g/1000 ml+ 1.6 g/1000

b.braun adria bh d.o.o. - aminokiseline, elektroliti - otopina za infuziju - 5 g/1000 ml+ 8.9 g/1000 ml+ 6.85 g/1000 ml+ 4.4 g/1000 ml+ 4.7 g/1000 ml+ 4.2 g/1000 ml+ 1.6 g/1000 ml+ 6.2 g/1000 ml+ 11.5 g/10 - 1000 ml otopine za infuziju sadrži: 5,00 g izoleucin 8,90 g leucin 6,85 g lizin (u obliku lizinhidrohlorida) 4,40 g metionin 4,70 g fenilalanin 4,20 g treonin 1,60 g triptofan 6,20 g valin 11,50 g arginin 3,00 g histidin 10,50 g alanin 12,00 glicin 7,20 g glutaminska kiselina 5,50 g prolin 2,30 g serin 5,60 g aspartatna kiselina 0,40 g tirozin 2,858 g natrijumacetat, trihidrat 0,360 g natrijumhidroksid 2,453 g kalijumacetat 0,508 g magnezijumhlorid, heksahidrat 3,581 g natrijumfosfat, dodekahidrat

Intuniv Unión Europea - croata - EMA (European Medicines Agency)

intuniv

takeda pharmaceuticals international ag ireland branch - guanfacin hidroklorid - deficit poremećaja pozornosti s hiperaktivnošću - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv bi trebao biti korišten kao dio integriranog programa za liječenje adhd-om, kao i obično, uključujući psihološke, obrazovne i socijalne mjere.

CALGEL 3.3 mg/1 g+ 1 mg/1 g gel za desni Bosnia y Herzegovina - croata - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

calgel 3.3 mg/1 g+ 1 mg/1 g gel za desni

glaxosmithkline d.o.o.sarajevo - cetilpiridin, lidokain - gel za desni - 3.3 mg/1 g+ 1 mg/1 g - 1 g gela za desni sadrži: 3,3 mg lidokainhidrohlorid 1,0 mg cetilpiridinijumhlorid

ROTARIX ≥ 10 megaCCID50/1.5 mL oralna suspenzija Bosnia y Herzegovina - croata - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

rotarix ≥ 10 megaccid50/1.5 ml oralna suspenzija

glaxosmithkline d.o.o.sarajevo - virus rota drugarima, živi, atenuisani - oralna suspenzija - ≥ 10 megaccid50/1.5 ml - 1,5 ml oralne suspenzije (1 doza) sadrži: humani rotavirus, živi, atenuirani, soj rix4414 ne manje od 10 na šestu ccid50

CALGEL 3.3 mg/1 g+ 1 mg/1 g gel za desni Bosnia y Herzegovina - croata - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

calgel 3.3 mg/1 g+ 1 mg/1 g gel za desni

evropa lijek pharma d.o.o. - cetilpiridin, lidokain - gel za desni - 3.3 mg/1 g+ 1 mg/1 g - 1 g gela za desni sadrži: 3,3 mg lidokainhidrohlorid 1,0 mg cetilpiridinijumhlorid

Celdoxome pegylated liposomal Unión Europea - croata - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - doksorubicin hidroklorid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastična sredstva - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).